We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NTBLQ market cap is 10.63k. The company's latest EPS is USD -1.1661 and P/E is -0.21.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 562k | 922k | 768k | 658k | 310k |
| Operating Income | -20.01M | -24.48M | -30M | -32.85M | -14.66M |
| Net Income | -19.46M | -24.23M | -29.92M | -32.3M | -11.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.62M | 41.71M | 64.66M | 29.66M | 19.54M |
| Total Liabilities | 12.78M | 10.79M | 12.48M | 7.21M | 4.43M |
| Total Equity | 35.84M | 30.92M | 50.58M | 22.45M | 15.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.7M | -23.38M | -24.98M | -31.59M | -13.72M |
| Investing | -6.6M | 9.89M | -15.49M | 27.3M | 15.54M |
| Financing | -757k | 17.07M | 49.11M | 22k | 7.82M |
| Market Cap | 10.63k |
| Price to Earnings Ratio | -0.21 |
| Price to Sales Ratio | 7.79 |
| Price to Cash Ratio | 0.2 |
| Price to Book Ratio | 0.16 |
| Dividend Yield | - |
| Shares Outstanding | 9.66M |
| Average Volume (1 week) | 63.98k |
| Average Volume (1 Month) | 30.75k |
| 52 Week Change | -99.12% |
| 52 Week High | 0.225 |
| 52 Week Low | 0.001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Notable Labs Ltd (CE) |
| Address |
8 hasatat st modi'in-maccabim-re'ut, center 7178106 |
| Website | https://www.vblrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
